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What motivates a physician to inflict disease on his own person—the tenacity to establish the truth, a passion for research 
whatever the cost, frustration with unbelieving 
peers or sheer bravado in one’s own invincibility? 
The history of medical discoveries is replete with 
tales of individuals whose pursuit of knowledge and 
self-belief prompted them to become human guinea 
pigs. The outcome of their self-experimentation 
ranged anywhere from mortality to a cure. Accolades, 
including the Nobel Prize, were the reward for a few. 
One thing is certain: their feats have become the lore 
of medical literature that generations of physicians 
will remember with astonishment and admiration. 
This article focuses on a recent notable example of the 
discovery of the bacterial origin of gastritis followed by 
a brief mention of other heroic exploits. Many of these 
are an inspiration to physicians when research efforts 
go unrequited and disappointments take their toll.
Dogma and Disbelief 
Demolished
In 2005, the Karolinska Institute in Stockholm, 
Sweden, awarded the Nobel Prize in Medicine or 
Physiology to J. Robin Warren and Barry J. Marshall 
for their discovery of a bacterial cause of gastritis and 
peptic ulcer disease.2 The pathologist-physician duo 
were paid homage for the struggle they encountered 
in establishing a revolutionary concept—a bacterial 
aetiology in the pathophysiology of gastric disease. 
This recognition was almost an oddity in a century 
when awards were usually given for research on genes 
and subcellular biochemical processes.3 
In his lecture during the Nobel Prize ceremony 
in December 2005, Warren eloquently quoted the 
fictional detective Sherlock Holmes: “There is nothing 
more deceptive than an obvious fact”.4 He was referring 
to the reaction of the medical fraternity when he 
initially proposed that a spiral-shaped bacteria could 
be found in the stomach. It defied the wisdom of the 
centuries which stated that the acid environment 
of the stomach could not possibly permit bacterial 
growth. H2-receptor antagonists, the commercial 
jackpot of the 20th century pharmaceutical industry, 
have acid-lowering capacities, but treat rather than 
cure ulcers.5 Warren had first observed these bacteria 
in a gastric biopsy on 11 June 1979 (his 42nd birthday).6 
Bacteria had been seen by others in the gastric mucosa 
but they were largely considered to be contaminants. 
The implication that an infection caused stomach 
inflammation or ulcers contradicted the firm belief 
that lifestyle and stomach acidity were the culprits.6 
Warren’s training as a pathologist, his passion for 
staining techniques (especially silver stains) and his 
persistence stood him in good stead when he doggedly 
pursued his discovery with other tools of the trade: 
electron microscopy and, later, bacterial cultures.
Warren’s lonely two-year quest received a boost 
when, in 1981, a gastroenterology registrar, Marshall, 
became his clinical collaborator. The physician-
pathologist partners took their research a step further 
with a systematic collection of gastric antral biopsies 
which allowed them to observe microscopic changes 
in symptomatic patients without the confounding 
histological changes that biopsies from ulcer edges 
produced. Their attempts to characterise the bacteria, 
referred to as Campylobacter-like organisms, were 
met with disappointment until a fortuitous failure 
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to discard cultures over the Easter holiday in April 
1982 resulted in colonies appearing on the culture 
plate.7 This was the Eureka moment following many 
disappointing months of collecting and delivering 
specimens to the microbiology laboratory with a 
negative outcome. Routinely, culture plates had been 
discarded after 48 hours; however, the new bacterium 
needed five days to grow. The organism was later 
classified as Helicobacter pylori.4 
In 1983 and 1984, Warren and Marshall published 
their findings in a prestigious medical journal, The 
Lancet, after stiff resistance from reviewers.8,9 Initial 
reactions to these pioneering publications stood in 
sharp contrast to the laudatory interviews and expert 
editorials in leading scientific journals which followed 
when the duo’s work was recognised by the Nobel 
Committee just over two decades later.7,10,11 After the 
initial publications, worldwide interest grew rapidly; 
however, Marshall still had to convince disbelievers 
that H. pylori was the cause of gastritis and peptic 
ulcers, since no effective animal model had yet proven 
its pathogenicity.5 In late 20th century medical practice, 
where ethical clearance for a human experiment was 
very difficult to come by, he decided to establish 
the disease in his own body. Marshall managed 
to obtain a pre-experiment endoscopic biopsy to 
establish baseline observations. To aid the bacteria 
in establishing themselves in his stomach mucosa, he 
reduced his stomach acid by consuming cimetidine, 
drank the bacterial culture and fasted for the rest of 
the day.12 He developed bloating, nausea and vomiting 
with night sweats and halitosis after three days. The 
subsequent biopsy irrefutably established the bacterial 
presence on stains and cul-tures.12 After 14 days, 
the symptoms and the bacteria vanished from the 
mucosal biopsies, apparently due to his own immune 
response. However, Marshall had fulfilled Robert 
Koch’s postulates for identifying the causative agent of 
a disease and proven that the bacterium was a cause of 
gastric inflammation.12
Personal anecdotes marked this journey of 
discovery. Warren credits the support of his wife for 
helping him remain on course despite the deterrence 
meted by his peers.10 Marshall’s wife Adrienne had also 
noted his “putrid breath” in the wake of his drinking 
the H. pylori cocktail without her knowledge.5 The bold 
experiment may have earned him marital disfavour, 
but was instrumental in generating an era of antibiotic 
treatment for gastritis disorders. H. pylori became the 
first bacteria to be linked to carcinogenesis (gastric 
adenocarcinomas and lymphomas) in the research 
that followed.13
The Heart of the Matter
Cardiac catheterisation appears today as a straight-
forward, even routine procedure for a practicing 
cardiologist. But when the idea first gained 
momentum in the mind of a young German doctor, 
Werner Forssmann, in 1929, it was nothing short 
of revolutionary. Deriving inspiration from having 
witnessed the drawings of French physiologists who 
were able to access the heart chambers through the 
jugular vein in animals, he was convinced it was a 
workable idea.14 He tested his theory by introducing 
a ureteric catheter through his brachial vein and into 
his heart. The unconventional step needed not only 
personal grit but also involved considerable artifice in 
convincing both the head nurse to part with sterilised 
instruments and the radiographer to record the 
historical moment.14
Not Always for the Right 
Reasons
Another bacterial experiment in the 19th century did 
not achieve the same success that Warren did with 
H. pylori. Max von Pettenkofer was Koch’s antagonist 
and argued vociferously against contagion (infection) 
being the cause of disease.15 As such, he opposed 
the public health water hygiene measures designed 
to prevent water-borne infections like cholera. In a 
desperate attempt to prove his point, he swallowed the 
cholera bacillus; since he fortunately failed to develop 
the disease, he felt vindicated in standing his ground 
despite his incorrect aetiological hypothesis.15
Team Spirit in Medical 
Experiments
From the fold of military medicine came the 
triumphant discovery that a mosquito, later identified 
as Aedes aegypti, was the vector of yellow fever. In 
1900, Major Walter Reed, a surgeon in the USA 
Army, led the U.S. Army Yellow Fever Board to Cuba. 
Although he was one of the members, Reed himself did 
not submit to being bitten by infected mosquitoes and 
it was his compatriot, Jesse W. Lazear, who succumbed 
to infection in the search for truth.16 Reed was hailed 
as a hero for saving countless lives in Havana, Cuba. 
However, the fact that many of his so-called volunteers 
were members of his team of health professionals 
casts a long shadow on the dynamic team leader who 
extracted a human cost from his intrepid followers. 
Another member of this loyal band was Clara Maass, 
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for its revival in a modified form.20 She supports the 
practice for the accuracy of self-observation, the 
lack of complete replication of the human situation 
in animal models and the clear academic and moral 
arguments for doing unto oneself before inflicting 
others. She even emphasises a leadership element, 
whereby medical professionals can lead by example 
before seeking informed consent from patients or 
healthy volunteers.20 Additionally, Dresser points out 
hitherto undisclosed aspects of research she learnt as a 
volunteer, such as delays in treatment or the possibility 
of trials being prematurely stopped or remaining 
unfinished. In her own words, “Personal exposure led 
me to understand the heavy burdens such a duty would 
impose on seriously ill patients”.20 The institutional 
review boards and ethics committees of today do not 
always include this aspect of trials in their remits and 
may therefore need to expand their ambit. 
What then is the way forward? It is our conviction 
that we have not seen the last of this breed of 
researchers who would risk all to pursue a strongly held 
hypothesis. It is equally certain that formal approval 
through ethical committees will be hard to obtain 
given the legal implications, with some experiments 
potentially being equated with suicide. Yet, if the 
experimenters survive to tell their tale, the scientific 
community invariably embraces the new fact. There 
is another alternative—leaders of research teams 
may do well to pay heed to out-of-the-box ideas from 
their mentees and allow them the latitude to confirm 
or dismiss them through experimentation, rather 
than self-experimentation. Lone rangers, however, 
may still make the critical decision to experiment on 
themselves, sometimes only to prevent an original 
idea from being plagiarised. Therein lie the dangers of 
the human frailties of possession and secrecy.
Lessons from the History of 
Self-Experimentation
Altruistic, audacious or simply foolhardy, these 
mavericks of medicine have earned veneration from 
the world in general and young physicians in particular. 
Medical pioneers and researchers who travelled this 
path through self-example and self-sacrifice have 
demonstrated the boldness and recklessness that 
creates legends. Adversity kept them undaunted in 
their mission; derision and mockery by their peers 
pushed them to bravado. Whether it earned them 
fame, notoriety or an untimely death, in many cases 
both clinical research and humankind have benefited 
from self-experimentation. 
a 25-year old American nurse-volunteer, who also 
succumbed to the disease in 1901.17
Zealous researchers were sometimes not beyond 
including their family members in their crusades. 
Jonas Salk and his wife and children received the 
attenuated polio vaccine early in its trials, before 
millions of children known as ‘Polio Pioneers’ were 
officially tested in 1954 to determine the efficacy of 
the drug.1 
Inspiration and Aftermath
Curiosity, convenience or self-conviction? Perhaps 
they all played complementary roles in driving these 
explorers to what may seem to be illogical risk-taking 
behaviours. Notably, 12 individuals who performed 
self-experiments—including Ramsay who exposed 
himself to anaesthetic gases, Lawrence who drank 
radioactive sodium, Metchnikoff who self-injected 
relapsing fever spirochaetes and Forssmann who 
performed self-cardiac catheterisation—were awarded 
Nobel Prizes, although not necessarily for these 
specific experiments. In an interesting review of auto-
experimenters dating from 1800, 465 episodes came 
to light.18 Tragically, at least eight self-experimenters 
died as a result of their research adventures in the 
field of infectious disease. Geographically, the self-
experimenters were mostly from the USA (33%) 
followed by Germany (15%); in terms of gender, there 
were 12 women, the majority of whom were Russian.18
Conclusions drawn from such misadventures 
were sometimes misdirected. The famous Scottish 
surgeon, John Hunter, set out to straighten the record 
on gonorrhoea and syphilis. These were thought to 
be the same disease: the first visible by its urethral 
discharge, the second developing more systemic 
manifestations.19 Reports that he self-infected himself 
with pus derived from the genital sore of a prostitute 
in 1767, succeeding in contracting both gonorrhoea 
and syphilis simultaneously, have been controversial. 
Nevertheless, these resulted in his putting forward 
a misleading conviction that these two sexually 
transmitted diseases were caused by a common 
pathogen which was later proven wrong.19
Self-Experimentation: The 21st 
century avatar
These instances detailed above beg the question—is 
self-experimentation relevant in the 21st century? In 
a recent exposition on the subject, Dresser argues 
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